Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
32 studies found for:    " September 24, 2008":" October 24, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" September 24, 2008":" October 24, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Spatial Epidemiology of HIV Infection
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Intervention:
2 Terminated Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1
Condition: Human Immunodeficiency Virus
Interventions: Drug: 3-drug anti-HIV therapy;   Drug: Raltegravir
3 Terminated
Has Results
Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease
Condition: Acquired Immune Deficiency Syndrome
Interventions: Drug: Lopinavir 400 mg/ritonavir 100 mg;   Drug: Efavirenz
4 Active, not recruiting HIV Risk Reduction in Youth in the Bahamas
Condition: HIV Infections
Interventions: Behavioral: FOYC;   Behavioral: Goal for it (GFI);   Behavioral: Wonderous Wetlands;   Behavioral: Caribbean Informed Parents and Children Together (CImPACT);   Behavioral: Bahamian Focus on Older Youth (BFOOY);   Behavioral: Health and Family Life Curriculum (HFLE)
5 Recruiting Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults
Conditions: Cardiovascular Disease;   HIV Infections
Intervention:
6 Completed Pilot Opened Trial in HIV-infected Patients Including an Investigational Marketed Product
Condition: HIV Infections
Interventions: Drug: raltegravir;   Drug: 1 P inhibitor + 2 nucleoside reverse transcriptase inhibitor or 1 non-nucleoside reverse transcriptase inhibitor + 2 nucleoside reverse transcriptase inhibitor
7 Recruiting Analysis of HIV-1 Replication During Antiretroviral Therapy
Condition: HIV Infection
Intervention:
8 Completed
Has Results
Comparison of Liquid Kaletra and Low Dose Kaletra Tablets
Condition: HIV Infections
Intervention: Drug: Low dose Kaletra tablets
9 Completed
Has Results
Antiretroviral Therapy Intensification With Raltegravir or Addition of Hyper-immune Bovine Colostrum in HIV-1 Infected Patients With Suboptimal CD4+ T Cell Response
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Hyper-immune Bovine Colostrum;   Other: raltegravir placebo;   Other: Hyper-immune Bovine Colostrum placebo;   Drug: raltegravir and hyper-immune bovine colostrum
10 Completed Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis in Patients With HIV?
Conditions: Latent Tuberculosis;   HIV Infections
Intervention: Other: T-Spot.TB test
11 Completed Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients
Condition: HIV Infections
Interventions: Drug: Raltegravir and truvada;   Drug: Atazanavir, Norvir and Truvada
12 Completed PENNVAX-B With or Without IL-12 or IL-15 as a DNA Vaccine for HIV Infection
Condition: HIV Infection
Interventions: Biological: PENNVAX-B;   Biological: GENEVAX IL-12-4532;   Biological: PLACEBO;   Biological: IL-15 adjuvant
13 Completed HIV-1 Specific Immune Responses in Thai Individuals With HIV Dementia
Condition: HIV Infections
Intervention:
14 Completed
Has Results
A Study of Raltegravir in a Diverse Cohort of HIV-Infected Patients (0518-055)
Condition: Human Immunodeficiency Virus
Intervention: Drug: Comparator: raltegravir
15 Completed GSK1349572 Drug Interaction Study With Protease Inhibitors
Conditions: Healthy Subjects;   Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK1349572
16 Unknown  An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin
Conditions: HIV Infection;   Tuberculosis
Intervention: Drug: Rifampin
17 Completed Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected Antiretroviral Treatment Experienced Children and Adolescents
Condition: HIV Infections
Intervention: Drug: Vicriviroc
18 Completed A Pilot Study to Characterize the Pharmacokinetics of Raltegravir in the Cervicovaginal Fluids of HIV-infected Women
Conditions: HIV;   AIDS
Intervention: Drug: Raltegravir (Isentress®)
19 Completed TMC125-TiDP2-C197: A Phase I Trial to Investigate the Pharmacokinetic Interaction Between Lopinavir/Ritonavir and TMC125 Both at Steady-state in Healthy Volunteers.
Condition: HIV
Intervention: Drug: Etravirine; Lopinavir; Ritonavir
20 Completed Influenza Vaccine in HIV
Conditions: Influenza;   HIV
Intervention: Biological: Fluviral

   Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results    Last Page
Indicates status has not been verified in more than two years